BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6822738)

  • 21. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first component of human complement: on the mechanism of activation by some carbohydrates.
    Schultz DR; Arnold PI
    J Immunol; 1981 May; 126(5):1994-8. PubMed ID: 7217678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the early components of the classical complement pathway under physiologic conditions.
    Ziccardi RJ
    J Immunol; 1981 May; 126(5):1769-73. PubMed ID: 7217665
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA; Woo P; Peters DK
    Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
    Ouaissi MA; Auriault C; Santoro F; Capron A
    J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the classical complement pathway in human serum by a small oligosaccharide.
    Dieminger L; Schultz DR; Arnold PI
    J Immunol; 1979 Nov; 123(5):2201-11. PubMed ID: 489979
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury.
    Murohara T; Guo JP; Delyani JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):499-507. PubMed ID: 8749222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified low density lipoproteins differentially bind and activate the C1 complex of complement.
    Biró A; Thielens NM; Cervenák L; Prohászka Z; Füst G; Arlaud GJ
    Mol Immunol; 2007 Feb; 44(6):1169-77. PubMed ID: 16938346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    Hirsch RL; Winkelstein JA; Griffin DE
    J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263
    [No Abstract]   [Full Text] [Related]  

  • 37. [Complement fixation ability of precipitating and co-precipitating antibodies of various animal species].
    Perdigón G; Gentile T; Margni A
    Rev Argent Microbiol; 1979; 11(1):1-6. PubMed ID: 538236
    [No Abstract]   [Full Text] [Related]  

  • 38. The activation of complement components by aggregates of antibodies and their fragments.
    Dodds AW; Porter RR
    Mol Immunol; 1979 Dec; 16(12):1059-62. PubMed ID: 542202
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions.
    Baker LA; Campbell PA; Hollister JR
    J Immunol; 1977 Nov; 119(5):1723-6. PubMed ID: 410883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.